Literature DB >> 25820215

Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility.

Qiang Huo1, Tao Li, Peiqing Zhao, Lianqing Wang.   

Abstract

Recently, the association of a single nucleotide polymorphism rs6812193 C/T with sporadic Parkinson's disease (PD) susceptibility has been widely evaluated, but the results remained inconsistent. This association should be clarified because of the importance of it on human health and quality of life. We performed a comprehensive meta-analysis to evaluate the association between the rs6812193 polymorphism and sporadic PD. PubMed was used to retrieve articles published up to June 2014 for all studies evaluating the rs6812193 polymorphism and PD in humans. Ethnicity-specific subgroup analysis was also performed based on ethnicity susceptibility. A total of 17 independent study samples (15 Caucasians and 2 Asians) including 17,956 cases and 52,751 controls were used in the presented study. The MAFT (minor allele T frequency) in PD patients of European descent is obviously higher than Asian cases (p < 0.01). The results suggested the rs6812193 polymorphism (allele T vs. C) is significantly associated with PD susceptibility among overall samples (OR 0.882, 95 % CI 0.856-0.908) and Caucasian population (OR 0.881, 95 % CI 0.856-0.907), but not in Asian samples (OR 0.918, 95 % CI 0.721-1.168). No evidence of publication bias was observed. Throughout our analysis, the rs6812193 polymorphism is significantly associated with sporadic PD susceptibility in Caucasian samples, and ethnicity might be the key point of inconsistency in rs6812193 studies. Further studies are warranted to re-examine the observed associations, especially in different ethnicities.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25820215     DOI: 10.1007/s10072-015-2186-1

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  9 in total

1.  Association study between two novel single nucleotide polymorphisms and sporadic Parkinson's disease in Chinese Han population.

Authors:  Kai Li; Bei-sha Tang; Ri-li Yu; Zhan-yun Lv; Qi-ying Sun; Qian Li; Kun Xia; Xin-xiang Yan; Ji-feng Guo
Journal:  Neurosci Lett       Date:  2012-04-15       Impact factor: 3.046

2.  Lack of replication of a previously reported association between polymorphism in the 3'UTR of the alpha-synuclein gene and Parkinson's disease in Chinese subjects.

Authors:  F-Y Hu; W-B Hu; L Liu; L-H Yu; J Xi; X-H He; M-R Zhu; Z-L Liu; Y-M Xu
Journal:  Neurosci Lett       Date:  2010-05-15       Impact factor: 3.046

3.  Association study of SCARB2 rs6812193 polymorphism with Parkinson's disease in Han Chinese.

Authors:  Shuai Chen; Yu Zhang; Wei Chen; Ying Wang; Jun Liu; Tian-Yi Rong; Jian-Fang Ma; Gang Wang; Jing Zhang; Jing Pan; Qin Xiao; Sheng-Di Chen
Journal:  Neurosci Lett       Date:  2012-03-23       Impact factor: 3.046

4.  Evidence of an association between the scavenger receptor class B member 2 gene and Parkinson's disease.

Authors:  Helen Michelakakis; Georgia Xiromerisiou; Efthimios Dardiotis; Maria Bozi; Demetrios Vassilatis; Persa-Maria Kountra; Gianna Patramani; Marina Moraitou; Dimitra Papadimitriou; Eleftherios Stamboulis; Leonidas Stefanis; Elias Zintzaras; Georgios M Hadjigeorgiou
Journal:  Mov Disord       Date:  2012-01-05       Impact factor: 10.338

5.  Disease-causing mutations within the lysosomal integral membrane protein type 2 (LIMP-2) reveal the nature of binding to its ligand beta-glucocerebrosidase.

Authors:  Judith Blanz; Johann Groth; Christina Zachos; Christina Wehling; Paul Saftig; Michael Schwake
Journal:  Hum Mol Genet       Date:  2009-11-20       Impact factor: 6.150

6.  Association study of rs6812193 polymorphism with Parkinson's disease in a Greek population.

Authors:  Kallirhoe Kalinderi; Sevasti Bostantjopoulou; Zoe Katsarou; Liana Fidani
Journal:  Neurosci Lett       Date:  2013-03-07       Impact factor: 3.046

7.  The role of SCARB2 as susceptibility factor in Parkinson's disease.

Authors:  Franziska Hopfner; Eva C Schulte; Brit Mollenhauer; Benjamin Bereznai; Franziska Knauf; Peter Lichtner; Alexander Zimprich; Dietrich Haubenberger; Walter Pirker; Thomas Brücke; Annette Peters; Christian Gieger; Gregor Kuhlenbäumer; Claudia Trenkwalder; Juliane Winkelmann
Journal:  Mov Disord       Date:  2013-02-13       Impact factor: 10.338

8.  A two-stage meta-analysis identifies several new loci for Parkinson's disease.

Authors: 
Journal:  PLoS Genet       Date:  2011-06-30       Impact factor: 5.917

9.  Web-based genome-wide association study identifies two novel loci and a substantial genetic component for Parkinson's disease.

Authors:  Chuong B Do; Joyce Y Tung; Elizabeth Dorfman; Amy K Kiefer; Emily M Drabant; Uta Francke; Joanna L Mountain; Samuel M Goldman; Caroline M Tanner; J William Langston; Anne Wojcicki; Nicholas Eriksson
Journal:  PLoS Genet       Date:  2011-06-23       Impact factor: 5.917

  9 in total
  3 in total

1.  Association of variants in microRNA with Parkinson's disease in Chinese Han population.

Authors:  Fang Li; Han Liu; Yuan Cheng; Jing Yang; Yutao Liu; Yanlin Wang; Zhihua Yang; Changhe Shi; Yuming Xu
Journal:  Neurol Sci       Date:  2017-12-05       Impact factor: 3.307

2.  No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.

Authors:  YongPing Chen; XiaoQin Yuan; Bei Cao; QianQian Wei; RuWei Ou; Jing Yang; XuePing Chen; Bi Zhao; Wei Song; Ying Wu; HuiFang Shang
Journal:  J Neural Transm (Vienna)       Date:  2015-07-30       Impact factor: 3.575

3.  Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2.

Authors:  Ria Thomas; Elizabeth B Moloney; Zachary K Macbain; Penelope J Hallett; Ole Isacson
Journal:  Mol Brain       Date:  2021-01-19       Impact factor: 4.041

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.